Evidence map›Paper›PMID 31209588›Full record

SynthesisLasers in medical science2020

Effects of low level laser therapy in cancer cells-a systematic review of the literature.

Jéssica Lúcio da Silva, Ana Flávia Spadaccini Silva-de-Oliveira, Rodrigo Antonio Carvalho Andraus, Luciana Prado Maia

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Lasers in medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jéssica Lúcio da SilvaLaboratory of Cell Culture, UEL/UNOPAR - University Pitágoras Unopar, Research Center in Health Sciences, Av. Paris, 675. Jd. Pizza, Londrina, PR, 86041-140, Brazil.
Ana Flávia Spadaccini Silva-de-OliveiraLaboratory of Cell Culture, UEL/UNOPAR - University Pitágoras Unopar, Research Center in Health Sciences, Av. Paris, 675. Jd. Pizza, Londrina, PR, 86041-140, Brazil.
Rodrigo Antonio Carvalho AndrausLaboratory of Cell Culture, UEL/UNOPAR - University Pitágoras Unopar, Research Center in Health Sciences, Av. Paris, 675. Jd. Pizza, Londrina, PR, 86041-140, Brazil.
Luciana Prado MaiaLaboratory of Cell Culture, UEL/UNOPAR - University Pitágoras Unopar, Research Center in Health Sciences, Av. Paris, 675. Jd. Pizza, Londrina, PR, 86041-140, Brazil. lucianapmaia@gmail.com.ORCID http://orcid.org/0000-0001-5697-2587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to conduct a systematic review regarding the use of photobiomodulation (PBM) therapy in tumoral cells, addressing the different types of lasers and parameters used. An electronic search was performed in PubMed/MEDLINE, Cochrane Library, and EMBASE databases. The inclusion criteria were being an in vitro study, with tumoral cells, and have at least one group of treatment with low-power laser and a control group (without treatment). Were excluded studies that used only non-carcinogenic cells, in vivo studies, studies that used high-power laser or the association with photosensitizers. The primary outcome evaluated was the cellular viability, and the secondary outcomes were the apoptosis rate and gene and inflammatory mediators' expression. Nineteen studies were identified among the lists of citations of studies that met the exclusion/inclusion criteria. There is a wide divergence regarding the wavelengths and doses used, as well as the type of laser, and each variation leads to different results, with some studies showing an increase in cell proliferation, while other studies showed a decrease. It is possible to suggest that PBM can be used in cancerous lesions in order to decrease the proliferation of these cells depending on the parameters used; however, the lack of standardization of laser irradiation protocols for in vitro investigations does not allow the establishment of ideal parameters for this purpose. Therefore, PBM should be used with caution in cancer patients until more studies are performed.

Indexed as

Low-Level Light TherapyApoptosisCell ProliferationCell SurvivalHumansNeoplasmsCancer cellLaser therapyLow level laser therapyNeoplasmsPhotobiomodulation therapyTumoral cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.